FindTrial
Sign In

Clinical effects of different anticoagulation protocols in ECMO patients

Clinical effects of different anticoagulation protocols in ECMO patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100151
Enrollment
Unknown
Registered
2025-04-03
Start date
2025-05-30
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical illness

Interventions

Standard ACT group:None
Moderate ACT group:None
Low ACT group:None

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients receiving ECMO treatment during study period.

Exclusion criteria

Exclusion criteria: 1. Under 18 years old; 2. ECMO support time referral after 24 hours; 5. Increase arteriovenous cannulation after 24 hours of ECMO support; 6. Pregnancy.

Design outcomes

Primary

MeasureTime frame
Oxygenator change;Complications during ECMO;—

Secondary

MeasureTime frame
Transfusion of human blood products during ECMO support;Number of days and total dose of vasoactive drugs;ECMO weaning success rate;ICU case fatality rate;In-hospital case fatality rate;Stay in the ICU for a long time;Total length of hospital stay;ICU cost;Total hospitalization costs;—

Countries

China

Contacts

Public ContactJia Liu

The Second Affiliated Hospital of Harbin Medical University

jialiu179@163.com+86 138 4507 6587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026